Drug Pipeline (in pharma context)
**What it means:** A "drug pipeline" is the entire journey a drug takes from the lab bench to the pharmacy shelf. Think of it as a factory assembly line: 1. **Discovery** → finding compounds that affe...
Explainers
Plain-English explanations of MEF2C research terms, concepts, and scientific mechanisms.
Preclinical Update (in gene therapy context)
**What it means:** "Preclinical" means research done **before human trials begin** — in cell cultures (in vitro) and animal models (in vivo). A "preclinical update" means the researchers have complete...
Oncology / Solid Tumor (in CDK2 inhibitor context)
**What it means:** Oncology is the branch of medicine that deals with cancer. "Solid tumors" are cancers that form actual lumps or masses (as opposed to blood cancers like leukemia). Breast, ovarian, ...
Clinical Readiness Study (vs. Clinical Trial)
**What it means:** A **"clinical readiness study"** is different from a full clinical trial. It's the work done *before* a trial to make sure the trial can actually happen. This includes: - **Patient ...
First-in-Human (FIH) Trial
**What it means:** This is the **very first time a drug is given to people** — never humans before, only animals (and cell cultures). It's essentially Phase 1a. The goals are: 1. **Safety** — does the...
Phase 1a/b Clinical Trial
**What the phases mean:** - **Phase 1a:** First-in-human testing. The primary goal is **safety** — "Is this drug safe in humans at all?" A small group of patients receives escalating doses to find the...
ctDNA (Circulating Tumor DNA)
**What it means:** Tumors shed tiny fragments of their DNA into the bloodstream — this is "circulating tumor DNA." By measuring ctDNA levels in a blood draw (a "liquid biopsy"), doctors can track canc...
CDK4/6 Inhibitor (related to MHS research)
**What it means:** CDK4 and CDK6 are proteins closely related to CDK2. They all work together to drive cell division. CDK4/6 inhibitors (like palbociclib, ribociclib, abemaciclib) are already FDA-appr...